miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells

Autor: Huaping Tang, Qiaojie Bi, Weihong Lv, Yueqin Hao, Wenxin Sun
Rok vydání: 2018
Předmět:
0301 basic medicine
Lung Neoplasms
medicine.disease_cause
Mice
0302 clinical medicine
Cell Movement
Genes
Reporter

Carcinoma
Non-Small-Cell Lung

Neoplasm Metastasis
Tumor Stem Cell Assay
Chemistry
Cell Cycle
NF-kappa B
Articles
General Medicine
Middle Aged
Cell cycle
Gene Expression Regulation
Neoplastic

030220 oncology & carcinogenesis
Female
RNA Interference
Signal Transduction
microRNA-505
Adult
Epithelial-Mesenchymal Transition
proliferation
MAP3K3
MAP Kinase Kinase Kinase 3
03 medical and health sciences
Cell Line
Tumor

microRNA
Genetics
medicine
Animals
Humans
Gene silencing
Protein kinase B
non-small cell lung cancer
Aged
Cell Proliferation
Neoplasm Staging
Oncogene
Cell growth
mitogen-activated protein kinase kinase kinase 3
AKT/nuclear factor-κB
MicroRNAs
030104 developmental biology
Cancer research
Carcinogenesis
Proto-Oncogene Proteins c-akt
Zdroj: International Journal of Molecular Medicine
ISSN: 1791-244X
1107-3756
DOI: 10.3892/ijmm.2018.4041
Popis: MicroRNAs (miRNAs) are short non-coding RNAs, which generally regulate gene expression at the post-transcriptional level. Dysregulation of miRNAs has been reported in numerous cancer types, including lung cancer. In the present study, the role of miR-505 in non-small cell lung cancer (NSCLC) cells was investigated. miR-505 served a tumor suppressor role in NSCLC cells. By reverse transcriptase-quantitative polymerase chain reaction detection, it was demonstrated that miR-505 was downregulated in NSCLC tissues and cell lines, which is negatively associated with large tumor size, Tumor-Node-Metastasis stage and distant metastasis in patients with NSCLC. Functional studies revealed that miR-505 inhibited cell proliferation, migration, invasion and epithelial-mesenchymal transition progress in vitro and tumor growth in vivo. Mechanically, mitogen-activated protein kinase kinase kinase 3 (MAP3K3) was identified as a direct target of miR-505 by binding to its 3′untranslated region and demonstrated to mediate the tumor suppressor roles of miR-505 in NSCLC cells. The effect of miR-505 on the activation of AKT/nuclear factor-κB (NFκB) pathway, which was downstream targets of MAP3K3, was further analyzed by western blot analysis and immunofluorescence analyses. The data demonstrated the inhibition of the AKT/NFκB pathway upon overexpressing miR-505 and the activation of AKT/NFκB pathway upon silencing miR-505. Collectively, the data revealed the novel role and target of miR-505 in NSCLC cells, which may provide novel insights regarding its role in the carcinogenesis of NSCLC and its potential values for clinical applications.
Databáze: OpenAIRE